Improvement of Nephrotoxicity, Hypertension, and Lipid Metabolism After Conversion of Kidney Transplant Recipients From Cyclosporine to Tacrolimus

By Friemann S.   Feuring E.   Padberg W.   Ernst W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1240-1242

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes

By Sundberg A.K.   Smith L.D.   Somerville K.T.   Cox R.   Sherbotie J.R.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1951-1952

Elsevier

Access to resources Recommend Favorite

Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels

By Artz M.A.   Boots J.M.M.   Ligtenberg G.   Roodnat J.I.   Christiaans M.H.L.   Hene R.J.   Blom H.J.   Demacker P.N.M.   Hilbrands L.B.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1793-1794

Elsevier

Access to resources Recommend Favorite

Cyclosporine to Tacrolimus: Effect on Hypertension and Lipid Profiles in Renal Allografts

By Copley J.B.   Staffeld C.   Lindberg J.   Hansen A.   Bailey C.   Anand R.   Van Veldhuisen P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1254-1256

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients

By Blume C.   Hollenbeck M.   Ivens K.   Heering P.   Hetzel G.R.   Grabensee B.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3161-3163

Elsevier

Access to resources Recommend Favorite